83_FR_61108 83 FR 60880 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

83 FR 60880 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 228 (November 27, 2018)

Page Range60880-60881
FR Document2018-25792

Federal Register, Volume 83 Issue 228 (Tuesday, November 27, 2018) 
[Federal Register Volume 83, Number 228 (Tuesday, November 27, 2018)]
[Notices]
[Pages 60880-60881]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-25792]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Treating Diabetes 
Distress to Improve Glycemic Outcomes in Type1 Diabetes.
    Date: December 17, 2018.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Paul A. Rushing, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7345, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-8895, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; NIDDK Crohn's Disease 
Ancillary Studies.
    Date: December 20, 2018.
    Time: 1:00 p.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Elena Sanovich, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,

[[Page 60881]]

Room 7351, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, (301) 
594-8886, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: November 20, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-25792 Filed 11-26-18; 8:45 am]
 BILLING CODE 4140-01-P

60880 Federal Register / Vol. 83, No. 228 / Tuesday, November 27, 2018 / Notices Contact Person: Majed M. Hamawy, Ph.D., Name of Committee: National Cancer Research; 93.397, Cancer Centers Support; Scientific Review Officer, Research Program Institute Special Emphasis Panel; Innovative 93.398, Cancer Research Manpower; 93.399, Review Branch, Division of Extramural Molecular Analysis Technologies. Cancer Control, National Institutes of Health, Activities, National Cancer Institute, NIH, Date: February 13–14, 2019. HHS) 9609 Medical Center Drive, Room 7W120, Time: 4:00 p.m. to 8:00 p.m. Dated: November 20, 2018. Bethesda, MD 20892–9750, 240–276–6457, Agenda: To review and evaluate grant applications. Melanie J. Pantoja, mh101v@nih.gov. Place: Bethesda North Marriott Hotel & Program Analyst, Office of Federal Advisory Name of Committee: National Cancer Committee Policy. Conference Center, 5701 Marinelli Road, Institute Special Emphasis Panel; NCI SPORE North Bethesda, MD 20852. [FR Doc. 2018–25791 Filed 11–26–18; 8:45 am] III (P50) Review. Contact Person: Jun Fang, Ph.D., Scientific Date: January 31–February 1, 2019. BILLING CODE 4140–01–P Review Officer, Research Technology and Time: 8:00 a.m. to 5:00 p.m. Contract Review Branch, Division of Agenda: To review and evaluate grant Extramural Activities, National Cancer applications. Institute, NIH, 9609 Medical Center Drive, DEPARTMENT OF HEALTH AND Place: Bethesda North Marriott Hotel & Room 7W634, Bethesda, MD 20892–9750, HUMAN SERVICES Conference Center, 5701 Marinelli Road, 240–276–5460, jfang@mail.nih.gov. North Bethesda, MD 20852. National Institutes of Health Contact Person: Paul Carins, Ph.D., Name of Committee: National Cancer Scientific Review Officer, Research Program Institute Special Emphasis Panel; NCI National Institute of Diabetes and Review Branch, Division of Extramural Program Project IV (P01) Review. Date: February 14–15, 2019. Digestive and Kidney Diseases; Notice Activities, National Cancer Institute, NIH, of Closed Meetings Time: 4:00 p.m. to 2:30 p.m. 9609 Medical Center Drive, Room 7W244, Agenda: To review and evaluate grant Pursuant to section 10(d) of the Bethesda, MD 20892–9750, 240–276–5415, applications. paul.cairns@nih.gov. Federal Advisory Committee Act, as Place: Gaithersburg Marriott Name of Committee: National Cancer Washingtonian Center, 9751 Washingtonian amended, notice is hereby given of the Institute Special Emphasis Panel; NCI Boulevard, Gaithersburg, MD 20878. following meetings. Program Project II (P01). Contact Person: Robert E. Bird, Ph.D., The meetings will be closed to the Date: February 6–7, 2019. Scientific Review Officer, Research Program public in accordance with the Time: 8:00 a.m. to 2:00 p.m. Review Branch, Division of Extramural provisions set forth in sections Agenda: To review and evaluate grant Activities, National Cancer Institute, NIH, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications. 9609 Medical Center Drive, Room 7W110, as amended. The grant applications and Place: Hilton Washington/Rockville Hotel, Bethesda, MD 20892–9750, 240–276–6344, the discussions could disclose 1750 Rockville Pike, Rockville, MD 20852. birdr@mail.nih.gov. Contact Person: Mukesh Kumar, Ph.D., confidential trade secrets or commercial Name of Committee: National Cancer property such as patentable material, Scientific Review Officer, Research Program Institute Special Emphasis Panel; NCORP Review Branch, Division of Extramural and personal information concerning Minority/Underserved Community Sites Activities, National Cancer Institute, NIH, individuals associated with the grant (UGIClinical Trial Required). 9609 Medical Center Drive, Room 7W618, Date: February 26–27, 2019. applications, the disclosure of which Bethesda, MD 20892–9750, 240–276–6611, Time: 5:00 p.m. to 5:00 p.m. would constitute a clearly unwarranted mukesh.kumar3@nih.gov. Agenda: To review and evaluate grant invasion of personal privacy. Name of Committee: National Cancer applications. Name of Committee: National Institute of Institute Special Emphasis Panel; NCI Place: Gaithersburg Marriott Diabetes and Digestive and Kidney Diseases Program Project III (P01) Review. Washingtonian Center, 9751 Washingtonian Special Emphasis Panel; Treating Diabetes Date: February 7–8, 2019. Boulevard, Gaithersburg, MD 20878. Distress to Improve Glycemic Outcomes in Time: 8:00 a.m. to 1:00 p.m. Contact Person: Scott Chen, Ph.D., Type1 Diabetes. Agenda: To review and evaluate grant Scientific Review Officer, Special Review Date: December 17, 2018. applications. Branch Division of Extramural Activities Time: 12:00 p.m. to 4:00 p.m. Place: Bethesda North Marriott Hotel & National Cancer Institute, NIH 9609 Medical Agenda: To review and evaluate grant Conference Center, 5701 Marinelli Road, Center Drive, Room 7W526, Bethesda, MD applications. North Bethesda, MD 20852. 20892–9750, 240–276–6038, chensc@ Place: National Institutes of Health, Two Contact Person: Sanita Bharti, Ph.D., mail.nih.gov. Democracy Plaza, 6707 Democracy Scientific Review Officer, Research Program Name of Committee: National Cancer Boulevard, Bethesda, MD 20892 (Telephone Review Branch, Division of Extramural Institute Initial Review Group; Subcommittee Conference Call). Activities, National Cancer Institute, NIH, J—Career Development. Contact Person: Paul A. Rushing, Ph.D., 9609 Medical Center Drive, Room 7W122, Date: February 28–March 1, 2019. Scientific Review Officer, Review Branch, Bethesda, MD 20892–9750, 240–276–5909, Time: 4:00 p.m. to 4:00 p.m. DEA, NIDDK, National Institutes of Health, sanitab@mail.nih.gov. Agenda: To review and evaluate grant Room 7345, 6707 Democracy Boulevard, Name of Committee: National Cancer applications. Bethesda, MD 20892–5452, (301) 594–8895, Institute Initial Review Group; NCI Program Place: Bethesda North Marriott Hotel & rushingp@extra.niddk.nih.gov. Project V (P01). Conference Center, 5701 Marinelli Road, Name of Committee: National Institute of Date: February 13–14, 2019. North Bethesda, MD 20852. Diabetes and Digestive and Kidney Diseases Time: 8:00 a.m. to 4:00 p.m. Contact Person: Tushar Deb, Ph.D., Special Emphasis Panel; NIDDK Crohn’s Agenda: To review and evaluate grant Scientific Review Officer, Resources and Disease Ancillary Studies. applications. Training Review Branch, Division of Date: December 20, 2018. Place: Gaithersburg Marriott Extramural Activities, National Cancer Time: 1:00 p.m. to 2:30 p.m. Washingtonian Center, 9751 Washingtonian Institute, NIH, 9609 Medical Center Drive, Agenda: To review and evaluate grant amozie on DSK3GDR082PROD with NOTICES1 Boulevard, Gaithersburg, MD 20878. Room 7W624, Bethesda, MD 20892–9750 applications. Contact Person: Adriana Stoica, Ph.D., 240–276–6132 tushar.deb@nih.gov. Place: National Institutes of Health, Two Scientific Review Officer, Resources and (Catalogue of Federal Domestic Assistance Democracy Plaza, 6707 Democracy Training Review Branch, Division of Program Nos. 93.392, Cancer Construction; Boulevard, Bethesda, MD 20892 (Telephone Extramural Activities, National Cancer 93.393, Cancer Cause and Prevention Conference Call). Institute, NIH, 9609 Medical Center Drive, Research; 93.394, Cancer Detection and Contact Person: Elena Sanovich, Ph.D., Room 7W234, Bethesda, MD 20892–9750, Diagnosis Research; 93.395, Cancer Scientific Review Officer, Review Branch, 240–276–6368, Stoicaa2@mail.nih.gov. Treatment Research; 93.396, Cancer Biology DEA, NIDDK, National Institutes of Health, VerDate Sep<11>2014 17:45 Nov 26, 2018 Jkt 247001 PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 E:\FR\FM\27NON1.SGM 27NON1

Federal Register / Vol. 83, No. 228 / Tuesday, November 27, 2018 / Notices 60881 Room 7351, 6707 Democracy Boulevard, Place: National Institutes of Health, 5601 Agenda: To review and evaluate grant Bethesda, MD 20892–2542, (301) 594–8886, Fishers Lane, Rockville, MD 20892 applications and/or contract proposals. sanoviche@mail.nih.gov. (Telephone Conference Call). Place: National Institutes of Health, (Catalogue of Federal Domestic Assistance Contact Person: Amir Emanuel Zeituni, Rockledge 6700, 6700 B Rockledge Drive, Program Nos. 93.847, Diabetes, Ph.D., Scientific Review Program, DEA/ Conference Rooms A, B & C, Bethesda, MD Endocrinology and Metabolic Research; NIAID/NIH/DHHS, 5601 Fishers Lane, MSC– 20817. 93.848, Digestive Diseases and Nutrition 9834, Rockville, MD 20852, 301–496–2550. Open: 10:00 a.m. to 3:00 p.m. Research; 93.849, Kidney Diseases, Urology (Catalogue of Federal Domestic Assistance Agenda: Presentations and other business and Hematology Research, National Institutes Program Nos. 93.855, Allergy, Immunology, of the Council. of Health, HHS) and Transplantation Research; 93.856, Place: National Institutes of Health, Microbiology and Infectious Diseases Rockledge 6700, 6700 B Rockledge Drive, Dated: November 20, 2018. Research, National Institutes of Health, HHS) Conference Rooms A, B & C, Bethesda, MD Melanie J. Pantoja, 20817. Dated: November 20, 2018. Program Analyst, Office of Federal Advisory Contact Person: Abraham P. Bautista, Committee Policy. Natasha M. Copeland, Ph.D., Executive Secretary, National [FR Doc. 2018–25792 Filed 11–26–18; 8:45 am] Program Analyst, Office of Federal Advisory Advisory Council, National Institute on Committee Policy. Alcohol Abuse & Alcoholism, National BILLING CODE 4140–01–P [FR Doc. 2018–25788 Filed 11–26–18; 8:45 am] Institutes of Health, 6700 B Rockledge Drive, BILLING CODE 4140–01–P Suite 1458, MSC 6902, Rockville, MD 20852, 301–443–9737, bautista@mail.nih.gov. DEPARTMENT OF HEALTH AND Any interested person may file written HUMAN SERVICES comments with the committee by forwarding DEPARTMENT OF HEALTH AND the statement to the Contact Person listed on National Institutes of Health HUMAN SERVICES this notice. The statement should include the name, address, telephone number and when National Institute of Allergy and National Institutes of Health applicable, the business or professional Infectious Diseases; Notice of Closed affiliation of the interested person. Meetings National Institute on Alcohol Abuse Information is also available on the and Alcoholism; Notice of Meeting Institute’s/Center’s home page: http:// Pursuant to section 10(d) of the www.niaaa.nih.gov/AboutNIAAA/ Federal Advisory Committee Act, as Pursuant to section 10(d) of the AdvisoryCouncil/Pages/default.aspx, where amended, notice is hereby given of the Federal Advisory Committee Act, as an agenda and any additional information for following meetings. amended, notice is hereby given of a the meeting will be posted when available. The meetings will be closed to the meeting of the National Advisory Council on Alcohol Abuse and (Catalogue of Federal Domestic Assistance public in accordance with the Program Nos. 93.271, Alcohol Research provisions set forth in sections Alcoholism. Career Development Awards for Scientists 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., The meeting will be open to the and Clinicians; 93.272, Alcohol National as amended. The grant applications and public as indicated below, with Research Service Awards for Research the discussions could disclose attendance limited to space available. Training; 93.273, Alcohol Research Programs; confidential trade secrets or commercial Individuals who plan to attend and 93.891, Alcohol Research Center Grants; property such as patentable material, need special assistance, such as sign 93.701, ARRA Related Biomedical Research language interpretation or other and Research Support Awards, National and personal information concerning Institutes of Health, HHS) individuals associated with the grant reasonable accommodations, should applications, the disclosure of which notify the Contact Person listed below Dated: November 20, 2018. would constitute a clearly unwarranted in advance of the meeting. Melanie J. Pantoja, The meeting will be closed to the Program Analyst, Office of Federal Advisory invasion of personal privacy. public in accordance with the Committee Policy. Name of Committee: National Institute of provisions set forth in sections Allergy and Infectious Diseases Special [FR Doc. 2018–25785 Filed 11–26–18; 8:45 am] 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Emphasis Panel; Immune Mechanisms of BILLING CODE 4140–01–P Protection Against Mycobacterium as amended. The intramural programs Tuberculosis Center (IMPAC–TB). and projects as well as the grant Date: December 6–7, 2018. applications and/or contract proposals DEPARTMENT OF HEALTH AND Time: 9:00 a.m. to 5:00 p.m. and the discussions could disclose HUMAN SERVICES Agenda: To review and evaluate contract confidential trade secrets or commercial proposals. property such as patentable material, National Institutes of Health Place: Doubletree Hotel Bethesda, 8120 and personal information concerning Wisconsin Avenue, Bethesda, MD 20814. individuals associated with intramural Submission for OMB Review; 30-Day Contact Person: Julio C. Aliberti, Ph.D., Comment Request Data and Specimen programs and projects as well as the Scientific Review Officer, Immunology grant applications and/or contract Hub (DASH) (Eunice Kennedy Shriver Review Branch, DEA/SRP, Rm. 3G53A, National Institutes of Health, NIAID, 5601 proposals, the disclosure of which National Institute of Child Health and Fishers Lane, MSC 9823, Rockville, MD would constitute a clearly unwarranted Human Development); Correction 20892–9823, 301–761–7322, julio.aliberti@ invasion of personal privacy. AGENCY: National Institutes of Health, nih.gov. Name of Committee: National Advisory HHS. Name of Committee: National Institute of Council on Alcohol Abuse and Alcoholism. Allergy and Infectious Diseases Special ACTION: Notice; correction. Date: February 7, 2019. amozie on DSK3GDR082PROD with NOTICES1 Emphasis Panel; ‘‘Acquired Closed: 9:00 a.m. to 9:20 a.m. SUMMARY: The Department of Health and Immunodeficiency Syndrome Research Agenda: Presentation of the AABSC Human Services, National Institutes of Review Committee (AIDS) Special Emphasis Report. Panel’’. Place: National Institutes of Health, Health published a Notice in the Date: December 19, 2018. Rockledge 6700, 6700 B Rockledge Drive, Federal Register on November 7, 2018. Time: 1:00 p.m. to 4:30 p.m. Conference Rooms A, B & C, Bethesda, MD That Notice inadvertently contained an Agenda: To review and evaluate grant 20817. error in the SUPPLEMENTARY INFORMATION applications. Closed: 9:20 a.m. to 10:00 a.m. section. VerDate Sep<11>2014 17:45 Nov 26, 2018 Jkt 247001 PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 E:\FR\FM\27NON1.SGM 27NON1


Document Created: 2018-11-27 01:24:55
Document Modified: 2018-11-27 01:24:55
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesDecember 17, 2018.
FR Citation83 FR 60880 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR